NeoStem's wholly owned subsidiary Progenitor Cell Therapy, LLC is an industry leader in contract development and manufacture of cell therapy products, akin to selling pickaxes during a gold rush. NeoStem does some gold mining of its own, targeting the mother lodes of heart disease and cancer, with therapeutic cell-therapy products entering Phase III trials.
http://ift.tt/16XMaFI
http://ift.tt/16XMaFI
No comments:
Post a Comment